Legal & General Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $99.6M | Buy |
|
|||||
|
2025
Q2 | $98M | Sell |
|
|||||
|
2025
Q1 | $87.5M | Buy |
|
|||||
|
2024
Q4 | $67.2M | Buy |
|
|||||
|
2024
Q3 | $73.2M | Buy |
|
|||||
|
2024
Q2 | $67.5M | Buy |
|
|||||
|
2024
Q1 | $71.9M | Sell |
|
|||||
|
2023
Q4 | $66.7M | Sell |
|
|||||
|
2023
Q3 | $69.1M | Buy |
|
|||||
|
2023
Q2 | $74.2M | Buy |
|
|||||
|
2023
Q1 | $81.2M | Buy |
|
|||||
|
2022
Q4 | $88.5M | Sell |
|
|||||
|
2022
Q3 | $91.5M | Buy |
|
|||||
|
2022
Q2 | $93.9M | Buy |
|
|||||
|
2022
Q1 | $82.8M | Buy |
|
|||||
|
2021
Q4 | $73.4M | Buy |
|
|||||
|
2021
Q3 | $54M | Buy |
|
|||||
|
2021
Q2 | $60.3M | Buy |
|
|||||
|
2021
Q1 | $61.2M | Buy |
|
|||||
|
2020
Q4 | $23.7M | Buy |
|
|||||
|
2020
Q3 | $1.11M | Sell |
|
|||||
|
2020
Q2 | $3.22M | Buy |
|